ROYAL PERTH HOSPITAL
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- -
- Established
- 1829-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
64
Active:2
Completed:24
Trial Phases
5 Phases
Phase 1:3
Phase 2:6
Phase 3:2
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (61 trials with phase data)• Click on a phase to view related trials
Not Applicable
38 (62.3%)Phase 4
12 (19.7%)Phase 2
6 (9.8%)Phase 1
3 (4.9%)Phase 3
2 (3.3%)Image Enhanced Endoscopy IBD
Not Applicable
Recruiting
- Conditions
- Inflammatory Bowel DiseasesDysplasia
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Royal Perth Hospital
- Target Recruit Count
- 270
- Registration Number
- NCT06266104
- Locations
- 🇦🇺
Royal Perth Hosptial, Perth, Western Australia, Australia
REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions.
Not Applicable
Recruiting
- Conditions
- Chronic Kidney DiseasesHeart FailureEnd Stage Renal Disease
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2023-01-30
- Lead Sponsor
- Royal Perth Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT05703620
- Locations
- 🇦🇺
Royal Perth Hospital, Perth, Western Australia, Australia
Role of Sympathetic Activation in Ischemia Reperfusion Injury
Phase 4
Completed
- Conditions
- Central Sympathetic Nervous System Diseases
- Interventions
- Other: placebo
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2022-09-29
- Lead Sponsor
- Royal Perth Hospital
- Target Recruit Count
- 46
- Registration Number
- NCT04479813
- Locations
- 🇦🇺
Dobney Hypertension Centre, Perth, Australia
Neuroinflammation in Hypertension Study
- First Posted Date
- 2020-07-20
- Last Posted Date
- 2022-09-29
- Lead Sponsor
- Royal Perth Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04478500
- Locations
- 🇦🇺
Royal Perth Hospital, Perth, Western Australia, Australia
Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension
Phase 4
Recruiting
- Conditions
- ObesityHypertension
- Interventions
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2022-09-29
- Lead Sponsor
- Royal Perth Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT04474899
- Locations
- 🇦🇺
Dobney Hypertension Centre, Perth, Western Australia, Australia
- Prev
- 1
- 2
- Next
News
No news found